Rare diseases
Investigational molecules
Locations
Back to Slovakia36 clinical trials in Petrzalka, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
SlovakiaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
SlovakiaStudy on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease
SlovakiaStudy on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
SlovakiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
SlovakiaStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
SlovakiaStudy of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo
SlovakiaStudy on the Effects of Upadacitinib in Adults and Adolescents with Non-Segmental Vitiligo Eligible for Systemic Treatment
SlovakiaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
SlovakiaStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
SlovakiaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
SlovakiaStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on cardiovascular diseases and preventive treatments, including studies on atherosclerosis, myocardial infarction, and stroke prevention.
Novel therapies being evaluated include inclisiran and pelacarsen for reducing cardiovascular events.
Research initiatives targeting metabolic conditions, with particular emphasis on obesity, diabetes, and lipid disorders management.
Studies evaluating new treatments like semaglutide and specialized medications for severe metabolic disorders.
Innovative research into autoimmune disorders, including trials for Sjögren's Syndrome, lupus, and chronic urticaria.
Testing advanced biologics and targeted therapies for autoimmune condition management.
Clinical research focusing on neurological disorders and mental health conditions, including schizophrenia and neurogenic conditions.
Evaluation of new therapeutic approaches for complex neurological disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
